---
title: "Laurus Labs Ltd (LAURUSLABS) — Share Price, Financials & Analysis"
symbol: "LAURUSLABS"
company: "Laurus Labs Ltd"
canonical: "https://tapetide.com/stocks/LAURUSLABS"
isin: "INE947Q01028"
nse_symbol: "LAURUSLABS"
bse_code: "540222"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 104478.44
generated_at: "2026-09-13T19:08:13.240Z"
---

# Laurus Labs Ltd (LAURUSLABS)

Canonical page: https://tapetide.com/stocks/LAURUSLABS

## Company

- **NSE Symbol:** LAURUSLABS
- **BSE Code:** 540222
- **ISIN:** INE947Q01028
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2016-12-19
- **CEO:** Dr. Satyanarayana Chava M.Sc., Ph.D.
- **Employees:** 6167
- **Face Value:** ₹2
- **F&O Eligible:** Yes
- **Website:** lauruslabs.com

## About

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership
position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (including High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.
Laurus employs 6,500+ people, including around 1,050+ scientists, at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc. [1]

## Latest Price

- **Price:** ₹1969
- **Change:** +24 (+1.23%)
- **Open:** ₹1943
- **Day High:** ₹1981.8
- **Day Low:** ₹1918.1
- **Previous Close:** ₹1945
- **Volume:** 2277375
- **As Of:** 2026-09-11T10:26:02+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:49.583124Z.

- **Market Cap:** ₹104478.44 Cr
- **Classification:** Midcap
- **P/E (reported):** 95.9
- **P/E (TTM):** 97.28
- **EPS (TTM):** ₹20.24
- **EPS (reported):** ₹2.75
- **Book Value:** ₹98.09
- **Price to Book:** 19.74
- **Dividend Yield:** 0.1%
- **ROE:** 16.38%
- **ROCE:** 19.67%
- **Debt to Equity:** 0.48
- **Revenue (yearly):** ₹6867.8 Cr
- **Net Income:** ₹889.9 Cr
- **EBITDA:** ₹1832.7 Cr
- **52-Week High:** ₹1955
- **52-Week Low:** ₹823.1
- **RSI (14):** 65.88

## Tapetide Score

- **Score:** 51 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 52 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 44.9 | 9% |
| growth | 70.18 | 9% |
| momentum | 94.48 | 12% |
| ownership | 48.08 | 24% |
| quality | 55.07 | 22% |
| valuation | 22.38 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has been maintaining a healthy dividend payout of 19.0%

### Weaknesses

- Stock is trading at 20.1 times its book value
- The company has delivered a poor sales growth of 7.19% over past five years.
- Company has a low return on equity of 10.1% over last 3 years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 169.84% | 143.88% | 78.19% |
| ebitda margin growth | 23.59% | 32.87% | 68.22% | -8.13% |
| net income growth | 28.36% | 151.1% | 4% | -2% |
| revenue growth | 11.63% | 22.01% | 4% | 7% |
| roce | 30.31% | 62.83% | 147.42% | 18.35% |
| roe | 28.35% | 112.73% | 9.39% | -33.9% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1224 | 1195 | 1440 | 1195 | 1224 | 1415 | 1720 | 1570 | 1653 | 1778 | 1812 | 2026 |
| Expenses | 1037 | 1014 | 1198 | 1024 | 1045 | 1130 | 1300 | 1187 | 1250 | 1298 | 1299 | 1388 |
| Operating Profit | 188 | 181 | 241 | 171 | 178 | 285 | 421 | 382 | 403 | 480 | 512 | 638 |
| OPM % | 15 | 15 | 17 | 14 | 15 | 20 | 24 | 24 | 24 | 27 | 28 | 32 |
| Other Income | 2 | 2 | 19 | 3 | 5 | 9 | 59 | 10 | 27 | 6 | 12 | 9 |
| Interest | 42 | 51 | 50 | 49 | 53 | 58 | 56 | 52 | 40 | 39 | 40 | 42 |
| Depreciation | 93 | 98 | 102 | 106 | 108 | 106 | 110 | 117 | 120 | 121 | 122 | 124 |
| Profit before tax | 54 | 35 | 107 | 18 | 23 | 131 | 312 | 224 | 270 | 327 | 361 | 481 |
| Tax % | 27 | 27 | 30 | 34 | 22 | 31 | 25 | 28 | 28 | 22 | 22 | 25 |
| Net Profit | 37 | 23 | 75 | 13 | 20 | 93 | 233 | 162 | 194 | 252 | 282 | 362 |
| EPS in Rs | 0.69 | 0.43 | 1.4 | 0.23 | 0.37 | 1.71 | 4.33 | 3.02 | 3.61 | 4.66 | 5.17 | 6.8 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2056 | 2292 | 2832 | 4814 | 4936 | 6041 | 5041 | 5554 | 6813 | 7270 |
| Expenses | 1642 | 1935 | 2266 | 3262 | 3512 | 4448 | 4261 | 4499 | 5028 | 5236 |
| Operating Profit | 414 | 357 | 565 | 1552 | 1424 | 1592 | 779 | 1055 | 1785 | 2034 |
| OPM % | 20 | 16 | 20 | 32 | 29 | 26 | 15 | 19 | 26 | 28 |
| Other Income | 29 | 15 | 5 | 23 | 14 | 6 | 24 | 75 | 47 | 54 |
| Interest | 80 | 88 | 90 | 68 | 102 | 165 | 183 | 216 | 171 | 161 |
| Depreciation | 125 | 164 | 187 | 205 | 251 | 324 | 385 | 430 | 480 | 487 |
| Profit before tax | 237 | 120 | 294 | 1301 | 1084 | 1109 | 236 | 484 | 1182 | 1439 |
| Tax % | 29 | 22 | 13 | 24 | 23 | 28 | 29 | 27 | 25 | — |
| Net Profit | 168 | 94 | 255 | 984 | 832 | 793 | 162 | 358 | 890 | 1091 |
| EPS in Rs | 3.16 | 1.76 | 4.77 | 18.33 | 15.4 | 14.67 | 2.98 | 6.64 | 16.46 | 20.24 |
| Dividend Payout % | 9 | 17 | 10 | 11 | 13 | 14 | 27 | 18 | 12 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 106 | 106 | 106 | 107 | 107 | 107 | 108 | 108 | 108 | 108 |
| Reserves | 1225 | 1377 | 1452 | 1663 | 2490 | 3244 | 3930 | 4003 | 4365 | 5192 |
| Borrowings | 842 | 980 | 1036 | 1079 | 1482 | 1777 | 2015 | 2577 | 2764 | 2518 |
| Other Liabilities | 481 | 554 | 737 | 901 | 1671 | 1840 | 1608 | 1699 | 2099 | 2693 |
| Total Liabilities | 2653 | 3017 | 3331 | 3750 | 5751 | 6968 | 7660 | 8387 | 9336 | 10511 |
| Fixed Assets | 1230 | 1481 | 1629 | 1726 | 2171 | 2652 | 3409 | 3890 | 4123 | 4371 |
| CWIP | 143 | 163 | 110 | 67 | 362 | 813 | 551 | 423 | 458 | 773 |
| Investments | 3 | 3 | 3 | 3 | 3 | 31 | 50 | 124 | 233 | 309 |
| Other Assets | 1277 | 1369 | 1589 | 1953 | 3214 | 3472 | 3651 | 3950 | 4521 | 5058 |
| Total Assets | 2653 | 3017 | 3331 | 3750 | 5751 | 6968 | 7660 | 8387 | 9336 | 10511 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 332 | 342 | 298 | 347 | 733 | 911 | 994 | 666 | 602 | 1624 |
| Cash from Investing Activity | -289 | -384 | -253 | -221 | -941 | -914 | -997 | -822 | -680 | -1086 |
| Cash from Financing Activity | -54 | 42 | -45 | -128 | 255 | 30 | -27 | 250 | 39 | -525 |
| Net Cash Flow | -10 | 1 | 0 | -1 | 47 | 27 | -30 | 93 | -39 | 13 |
| Free Cash Flow | 55 | -49 | 44 | 125 | 49 | 34 | 6 | -10 | 61 | 560 |
| CFO/OP | 94 | 98 | 91 | 68 | 62 | 77 | 80 | 99 | 70 | 107 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 109 | 101 | 113 | 102 | 99 | 100 | 96 | 120 | 132 | 115 |
| Inventory Days | 186 | 201 | 201 | 234 | 266 | 293 | 222 | 277 | 285 | 317 |
| Days Payable | 96 | 107 | 144 | 159 | 199 | 146 | 94 | 158 | 141 | 170 |
| Cash Conversion Cycle | 199 | 195 | 170 | 177 | 166 | 247 | 224 | 240 | 276 | 263 |
| Working Capital Days | 3 | -11 | 6 | 15 | 43 | 43 | 59 | 42 | 43 | 58 |
| ROCE % | 16 | 14 | 8 | 14 | 40 | 26 | 23 | 7 | 9 | 18 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 27.2% | 27.19% | 27.19% | 27.18% | 27.18% | 27.62% | 27.62% | 27.59% | 27.59% | 27.49% | 27.49% | 27.47% |
| FIIs | 24.03% | 25.39% | 25.97% | 25.67% | 26.08% | 25.56% | 25.52% | 25.7% | 26.16% | 26.52% | 25.82% | 28% |
| DIIs | 10.71% | 10.77% | 11.77% | 13.56% | 13.05% | 12.74% | 11.77% | 11.94% | 11.73% | 12.43% | 13.97% | 13.74% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.49% | 25.01% | 23.95% | 22.68% | 22.67% | 22.72% | 23.65% | 23.12% | 23.33% | 22.64% | 21.24% | 20.49% |
| Others | 11.57% | 11.64% | 11.12% | 10.91% | 11.03% | 11.36% | 11.44% | 11.65% | 11.18% | 10.92% | 11.47% | 10.3% |
| No. of Shareholders | 402640 | 382880 | 356830 | 324059 | 309063 | 292214 | 292905 | 280223 | 283678 | 280756 | 292281 | 291653 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 3 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1902.37 | Buy |
| EMA (10) | 1913.71 | Buy |
| SMA (20) | 1874.92 | Buy |
| EMA (20) | 1879.19 | Buy |
| SMA (50) | 1758.05 | Buy |
| EMA (50) | 1761.49 | Buy |
| SMA (100) | 1546.2 | Buy |
| EMA (100) | 1589.98 | Buy |
| SMA (200) | 1289.82 | Buy |
| EMA (200) | 1363.23 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 68.28 | Neutral |
| MACD (12,26,9) | 49.56 | Buy |
| Stochastic (14,3,3) | 92.04 | Sell |
| ADX (14) | 30.5 | Buy |
| Williams %R (14) | -6.91 | Sell |
| ATR (14) | 47.52 | Neutral |
| ROC (12) | 4.35 | Buy |
| Stoch RSI (14) | 68.57 | Neutral |
| UO (7,14,28) | 73.62 | Sell |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 5 | 41.67% |
| Hold | 3 | 25% |
| Sell | 4 | 33.33% |

Based on 12 analyst ratings, observed at 2026-09-11T04:44:49.577514+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a029a5b3-baf7-4817-be7b-8949db66c354.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87128dce-01bb-4640-aa15-64f56001a5f4.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e71214f3-dd3e-40c3-abe4-d4b9a516bdb7.pdf) |
| 2026-08-10 | [Intimation Of ESG Score Given By NSE Sustainability Ratings And Analytics Limited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a26dc397-f6b3-4988-86a5-0489ff15ebbf.pdf) |
| 2026-07-27 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2b2d849-3616-4c17-b58b-23fface2fc6d.pdf) |
| 2026-07-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0257cab1-847f-4f78-9fcf-e516b6c00582.pdf) |
| 2026-07-25 | [Update On Composite Scheme Of Arrangement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3377f190-b55b-4513-98dc-d77168ffc07e.pdf) |
| 2026-07-24 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d737d0c6-2a2c-49e6-8ee2-e566040264c6.pdf) |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d9e973b-786d-4e26-9c9a-b25b6eda0d0a.pdf) |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1b503cc-05ce-4c5c-80a4-c2a0b688cb86.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4a19b33-9fe2-4bd0-a9a5-6e92fce415d9.pdf) |
| 2026-05-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d12ab627-2b3d-4940-85ec-b46d30fb9f3d.pdf) |
| 2026-01-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=733ba0ea-bb83-4bac-b624-0414a23de9e9.pdf) |
| 2025-10-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=654c0e5d-8e0d-42be-a414-235d479ff4c3.pdf) |
| 2025-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a030198e-b134-4f95-86d5-d6a4ae7de8ab.pdf) |
| 2025-04-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b05cd9d-83da-4afb-9c97-02aadb8d0854.pdf) |
| 2025-01-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5a37d17-3cd2-46c3-be89-9dcf70b9c1ff.pdf) |
| 2024-10-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7dc7fcbb-ed78-4011-ae2a-91d6eae6891c.pdf) |
| 2024-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f472e1a8-6a1d-4b08-b517-20185dbaacbd.pdf) |
| 2024-04-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=196b260f-d297-4746-92ad-0acac8638329.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Results - Financial Results For Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2da54e1-1438-4d9c-bb30-2481eb3d8be8.pdf) |
| 2026-04-30 | [Results - Financial Results March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=789a6ad1-fbd1-4096-b38d-2b3e4ff636d0.pdf) |
| 2026-01-23 | [Results - Financial Results For Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1029229c-0a32-4970-b587-97a680bf2bc6.pdf) |
| 2025-10-23 | [Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a712afa-c933-4286-ae6a-7c35857aa136.pdf) |
| 2025-07-25 | [Unaudited Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5704577-f7fa-48fb-9670-37bb094b5d9b.pdf) |
| 2025-04-24 | [Results - Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97a69189-942a-4ebb-8209-fdca1f724058.pdf) |
| 2025-01-24 | [Results For The Quarter Ended 31.12.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f6294a-0346-4a9a-9dc8-baf1790984ae.pdf) |
| 2024-10-24 | [Results - Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2fc8f3b-ed4a-451f-b5d7-75cd64615fc2.pdf) |
| 2024-07-25 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6988078a-053b-4792-9288-d953fd33d93a.pdf) |
| 2024-04-25 | [Financials For Q4 FY 24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58a8514d-9069-48e1-afdf-a14d70eb492c.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77667f33-e7ac-4d89-9b67-da44963ef2d0.pdf) |
| 2026-04-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ee50d06-7f2d-4b47-b1f6-0e0334ba2886.pdf) |
| 2026-01-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8dd00f6-ba6a-437c-b95c-dc648f332cbd.pdf) |
| 2025-10-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e3fd55b-03fd-49b5-9b0b-664609c37d92.pdf) |
| 2025-09-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3146483d-2e4c-4a3a-b6df-9695d22569a5.pdf) |
| 2025-07-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=724ecf4e-219c-4603-840f-8cdcd8936daa.pdf) |
| 2025-04-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d7249f-f4c2-4781-a1c6-83671b2e7809.pdf) |
| 2025-01-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0b23002-a557-4284-ad80-f02cff3cf8a8.pdf) |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cad10ba-dc78-423f-8227-acf2e8478806.pdf) |
| 2024-07-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10885408-f7f3-430f-9719-a4294560e7c7.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Board meets April 30, 2026 to approve FY26 audited results and consider second interim dividend. | [Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Payment Of 2Nd Interim Dividend For FY 2025-26 9 Apr - Board meets April 30, 2026 to approve FY26 audited results and consider second interim dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4d33b8e-6fa9-4ecc-9ab2-3f181ec36e6b.pdf) |
| 7 Apr - Unsecured creditors approved Laurus Synthesis and Sriam Labs composite scheme on April 6, 2026. | [Update On Meetings Of Unsecured Creditors In Relation To The Composite Scheme Of Arrangement 7 Apr - Unsecured creditors approved Laurus Synthesis and Sriam Labs composite scheme on April 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08fa9f49-a067-492c-b13c-95a9ea16b68d.pdf) |
| 6 Mar - Laurus Labs to attend Investec India Conference Mar 12-13, 2026 in Hyderabad (in-person meetings). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Laurus Labs to attend Investec India Conference Mar 12-13, 2026 in Hyderabad (in-person meetings).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8d92145-aa26-4f82-85b9-3a2941b22914.pdf) |
| 30 Apr - Laurus Labs appoints Dr. Shekhar Mande and Ms. Sutapa Banerjee as independent directors from July 2, 2026; Aruna Bhinge retires July 6, 2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 30 Apr - Laurus Labs appoints Dr. Shekhar Mande and Ms. Sutapa Banerjee as independent directors from July 2, 2026; Aruna Bhinge retires July 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73df354c-9eb7-4881-9158-2a22977f0caa.pdf) |
| 30 Apr - Laurus Labs appoints Dr. Shekhar Mande and Ms. Sutapa Banerjee as independent directors from July 2, 2026; Aruna Bhinge retires July 6, 2026. | [Announcement under Regulation 30 (LODR)-Change in Directorate 30 Apr - Laurus Labs appoints Dr. Shekhar Mande and Ms. Sutapa Banerjee as independent directors from July 2, 2026; Aruna Bhinge retires July 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/73df354c-9eb7-4881-9158-2a22977f0caa.pdf) |
| 30 Apr - Board appoints two independent directors, notes one retirement, approves up to EUR 9.8 million investment in KRKA JV. | [Disclosure Pursuant To Regulation 30 Of The SEBI (LODR)Regulations, 2015 30 Apr - Board appoints two independent directors, notes one retirement, approves up to EUR 9.8 million investment in KRKA JV.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14ac8cf5-df92-4aad-adfd-e47bf619b461.pdf) |
| 30 Apr - Board appoints two independent directors, notes one retirement, approves up to EUR 9.8 million investment in KRKA JV. | [Disclosure Pursuant To Regulation 30 Of The SEBI (LODR)Regulations, 2015 30 Apr - Board appoints two independent directors, notes one retirement, approves up to EUR 9.8 million investment in KRKA JV.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14ac8cf5-df92-4aad-adfd-e47bf619b461.pdf) |
| 30 Apr - Audio recording of Q4 FY26 results conference call hosted on April 30, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Audio recording of Q4 FY26 results conference call hosted on April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b00d834c-00aa-49f1-a914-b63744ba822b.pdf) |
| 30 Apr - Audio recording of Q4 FY26 results conference call hosted on April 30, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Apr - Audio recording of Q4 FY26 results conference call hosted on April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b00d834c-00aa-49f1-a914-b63744ba822b.pdf) |
| 24 Feb - NCLT approved composite scheme (Feb 24, 2026); unsecured creditors' meetings April 06, 2026; 27:1 share exchange | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 24 Feb - NCLT approved composite scheme (Feb 24, 2026); unsecured creditors' meetings April 06, 2026; 27:1 share exchange](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d44a2c6-1192-4613-b8f1-9ef67cd9380f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3146483d-2e4c-4a3a-b6df-9695d22569a5.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/654c0e5d-8e0d-42be-a414-235d479ff4c3.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9cad10ba-dc78-423f-8227-acf2e8478806.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7dc7fcbb-ed78-4011-ae2a-91d6eae6891c.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be32b188-3a4e-4457-ba32-b6fc5370a192.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e392a81-22df-43f7-b198-d04b80309122.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d12ab627-2b3d-4940-85ec-b46d30fb9f3d.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7c12c7a-b883-4a4b-a6e2-2b302c2357b1.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a45977c4-0421-4aa4-a2a8-38e9905824ae.pdf) |
| Mar 2022 | [Concall - Mar 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee25186-fcec-4b2c-8510-6cef5b1bb8d4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18ee28e4-bc0d-4763-aa31-a381a4e120fd.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92aecede-6030-4ebb-beed-0ac0a6bb9c11.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b9617c3-923d-462a-9b45-5ebad3ce978d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4fa8009-74bf-4296-96d0-8e2539f9a07c.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/540222/73135540222.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-04-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a43e81bc-5f1a-4b81-8e7e-91bbe8deaaa7.pdf) |
| 2024-01-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3409b46b-87d9-406b-8166-ceb384b57242.pdf) |
| 2023-10-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=535b2c9b-79fa-4800-b6ad-433790138584.pdf) |
| 2023-07-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c50697c-4ece-48dc-bdb0-59210b8dd207.pdf) |
| 2023-04-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f1905cd-e683-4ee8-bf40-5e9147593a34.pdf) |
| 2023-01-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f7ac90a-25c5-458c-882a-5515e9f2faf6.pdf) |
| 2022-10-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6e0b9dd-eaa6-4f6f-8ebe-29a5a5e32783.pdf) |
| 2022-04-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6eb5e65-aacb-4121-ac3f-156af31fcc7d.pdf) |
| 2022-01-28 | [Audio Recording Of The Q3 9M FY22 Earnings' Conference Call Hosted On January 28, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c073479-7535-453b-a6bd-09086da1ef1d.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:08:13.240Z.